---
title: "Methodhub Software Ltd (544637) — Share Price, Financials & Analysis"
symbol: "544637"
company: "Methodhub Software Ltd"
canonical: "https://tapetide.com/stocks/544637"
isin: "INE0QZR01017"
nse_symbol: "METHODHUBSOFTWARELTD"
bse_code: "544637"
sector: "Information Technology"
industry: "Computer Software & Consulting"
market_cap_cr: 113.09
generated_at: "2026-09-13T20:15:39.920Z"
---

# Methodhub Software Ltd (544637)

Canonical page: https://tapetide.com/stocks/544637

## Company

- **NSE Symbol:** METHODHUBSOFTWARELTD
- **BSE Code:** 544637
- **ISIN:** INE0QZR01017
- **Sector:** Information Technology
- **Industry:** Computer Software & Consulting
- **Macro Sector:** Information Technology
- **Stock Type:** EQUITY
- **Listed Since:** 2025-12-12
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** methodhub.in

## About

Incorporated on 2016, MethodHub Software Ltd is an Information Technology (IT) services provider.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:33:50.345348Z.

- **Market Cap:** ₹113.09 Cr
- **Classification:** SME
- **P/E (reported):** 3.6
- **Book Value:** ₹81.2
- **Price to Book:** 0.74
- **Dividend Yield:** 0%
- **ROE:** 25.82%
- **ROCE:** 35.05%
- **Debt to Equity:** 0.74
- **Revenue (yearly):** ₹332.89 Cr
- **Net Income:** ₹40.38 Cr
- **EBITDA:** ₹65.11 Cr
- **52-Week High:** ₹171.95
- **52-Week Low:** ₹58.8
- **RSI (14):** 31.8

## Key Insights

### Strengths

- Stock is trading at 0.76 times its book value
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.8%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 26.8%

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 33.77% | -25% | -3.8% |
| ebitda margin growth | 45.77% | 12.62% | — |
| net income growth | 257.35% | 187% | — |
| revenue growth | 144.77% | 111% | — |
| roce | -5.98% | -2.75% | — |
| roe | -44.76% | 35.59% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 64 | 80 | 185 |
| Expenses | 55 | 65 | 150 |
| Operating Profit | 8 | 15 | 35 |
| OPM % | 13 | 18 | 19 |
| Other Income | 1 | 0 | 1 |
| Interest | 3 | 3 | 10 |
| Depreciation | 0 | 0 | 1 |
| Profit before tax | 7 | 12 | 25 |
| Tax % | 16 | 12 | 25 |
| Net Profit | 6 | 10 | 12 |
| EPS in Rs | 8.28 | 7.22 | 6.15 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 35 | 57 | 135 | 333 |
| Expenses | 29 | 48 | 118 | 268 |
| Operating Profit | 6 | 9 | 17 | 65 |
| OPM % | 18 | 16 | 13 | 20 |
| Other Income | 0 | 1 | 1 | 2 |
| Interest | 5 | 4 | 5 | 18 |
| Depreciation | 0 | 0 | 0 | 2 |
| Profit before tax | 2 | 6 | 13 | 47 |
| Tax % | 20 | 12 | 16 | 17 |
| Net Profit | 1 | 5 | 11 | 32 |
| EPS in Rs | 9.85 | 16.2 | 17.01 | 16.89 |
| Dividend Payout % | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 1 | 3 | 7 | 19 |
| Reserves | 3 | 8 | 36 | 134 |
| Borrowings | 26 | 29 | 32 | 113 |
| Other Liabilities | 11 | 5 | 19 | 77 |
| Total Liabilities | 41 | 45 | 94 | 344 |
| Fixed Assets | 0 | 4 | 10 | 107 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 3 | 0 | 0 | 0 |
| Other Assets | 38 | 41 | 83 | 237 |
| Total Assets | 41 | 45 | 94 | 344 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 7 | 4 | 5 | 6 |
| Cash from Investing Activity | -2 | -1 | -5 | -102 |
| Cash from Financing Activity | -5 | -2 | 8 | 139 |
| Net Cash Flow | 0 | 1 | 7 | 43 |
| Free Cash Flow | 7 | 4 | 4 | -93 |
| CFO/OP | 111 | 49 | 38 | 19 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 186 | 124 | 114 | 108 |
| Inventory Days | 0 | 0 | 14 | — |
| Days Payable | — | — | 88 | — |
| Cash Conversion Cycle | 186 | 124 | 40 | 108 |
| Working Capital Days | 75 | 79 | 58 | -6 |
| ROCE % | — | 28 | 31 | 37 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2025 | Dec 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Promoters | 35.29% | 26.85% | 26.85% |
| FIIs | 0% | 5.72% | 3.23% |
| DIIs | 0% | 8.99% | 3.52% |
| Government | 0% | 0% | 0% |
| Public | 0% | 29.66% | 32.7% |
| Others | 64.71% | 28.78% | 33.7% |
| No. of Shareholders | 107 | 128 | 1646 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 9 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 65.32 | Sell |
| EMA (10) | 64.74 | Sell |
| SMA (20) | 67.49 | Sell |
| EMA (20) | 67.05 | Sell |
| SMA (50) | 73.54 | Sell |
| EMA (50) | 72.45 | Sell |
| SMA (100) | 79.63 | Sell |
| EMA (100) | 81.79 | Sell |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 36.34 | Neutral |
| MACD (12,26,9) | -2.97 | Sell |
| Stochastic (14,3,3) | 22 | Neutral |
| ADX (14) | 21.57 | Neutral |
| Williams %R (14) | -79.58 | Neutral |
| ATR (14) | 3.88 | High Volatility |
| ROC (12) | -9.32 | Sell |
| Stoch RSI (14) | 32.9 | Neutral |
| UO (7,14,28) | 42.46 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6be9e3a-4570-4df8-a62d-c6163008af7a.pdf) |
| 2026-09-04 | [Shareholders Meeting - AGM- September 29 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7934f269-589f-4ce1-b4f9-2106dddc11ee.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34ef5b3a-8c3d-4ea9-ae43-0c9265d4d856.pdf) |
| 2026-09-04 | [Web Link For Annual Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5615bc1a-7cc0-44d8-a6d8-c5cd1c4eee87.pdf) |
| 2026-08-20 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=316dd315-7e36-4542-a839-88fd878750ed.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1ada348-5ace-4c70-b3bd-a4a8c86abd83.pdf) |
| 2026-08-08 | [Statement Of Deviation For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=903de7fd-7e80-4294-a31c-24a54e9d6b03.pdf) |
| 2026-07-14 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f67426-3368-4aff-9ad7-70a0793073c6.pdf) |
| 2026-07-06 | [Methodhub Partners With Datafoundry To Strengthen AI-Driven Pharmacovigilance (PV) And Pharma-Tech Offerings For Global Enterprises](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ad67d4f-abb5-4840-b46a-57d5c327ebac.pdf) |
| 2026-06-15 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15fd2f8d-cff1-4c73-bd3d-97cc70a6384e.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-26 | [Results- Half Year And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0c14b96-2d4c-48b1-958b-45d84c8dae34.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6h - Shareholders approved appointment of Aatman Alay Shah (Whole Time Director) and Arvind Nopany (Independent Director) effective 06-Mar-2026. | [Announcement under Regulation 30 (LODR)-Change in Management 6h - Shareholders approved appointment of Aatman Alay Shah (Whole Time Director) and Arvind Nopany (Independent Director) effective 06-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e3b0f390-cd12-451c-b102-a100e972a064.pdf) |
| 6h - Shareholders approved Aatman Alay Shah as Director/WTD, an independent director, and increased Aashay Shah's remuneration on 06-Mar-2026. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 6h - Shareholders approved Aatman Alay Shah as Director/WTD, an independent director, and increased Aashay Shah's remuneration on 06-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5c7ae157-b2cc-4f1d-a8cb-d428c27f7a58.pdf) |
| 6h - On 06-Mar-2026 shareholders approved appointing Aatman Alay Shah director/WTD, independent director appointment, and increased Aashay Shah's remuneration. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 6h - On 06-Mar-2026 shareholders approved appointing Aatman Alay Shah director/WTD, independent director appointment, and increased Aashay Shah's remuneration.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f7e911b5-9084-4f2c-8b6c-28ae9b7d7b66.pdf) |
| 6 May - MethodHub Software receives Great Place to Work certification for May 2026-May 2027, second consecutive year. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 May - MethodHub Software receives Great Place to Work certification for May 2026-May 2027, second consecutive year.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8981648f-b17f-458f-a6d7-41b0def8dd21.pdf) |
| 6 May - MethodHub launched CoAPP, an AI-enabled content organization and accelerated publishing platform. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 May - MethodHub launched CoAPP, an AI-enabled content organization and accelerated publishing platform.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/191a24d4-5750-4734-9ea9-b739e8395dd7.pdf) |
| 6 Feb - MethodHub to acquire 60% of Sewtech Inc. for USD 2.66 million; completion within 30 days. | [Board Meeting Outcome for Outcome Of Board Meeting 6 Feb - MethodHub to acquire 60% of Sewtech Inc. for USD 2.66 million; completion within 30 days.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ade73b63-5820-4be4-9abb-392067e90454.pdf) |
| 5 Feb - Board meeting Feb 06, 2026 to consider approval to acquire majority stake in a USA company. | [Board Meeting Intimation for Board Meeting Intimation 5 Feb - Board meeting Feb 06, 2026 to consider approval to acquire majority stake in a USA company.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0bef228b-7394-46e1-840e-de12d50ddc6a.pdf) |
| 4 Apr - Methodhub Software evaluating acquisition of up to 100% of a USA entity, subject to due diligence. | [Announcement Under Regulation 30 4 Apr - Methodhub Software evaluating acquisition of up to 100% of a USA entity, subject to due diligence.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d33aabc5-f3fd-4eaa-9049-9ecffee86036.pdf) |
| 31 Jan - Investor presentation for the quarter and nine months ended on 31st December, 2025. | [Announcement under Regulation 30 (LODR)-Investor Presentation 31 Jan - Investor presentation for the quarter and nine months ended on 31st December, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ba68b70-36b8-4dae-814a-22e06fd1237f.pdf) |
| 31 Jan - Board approved unaudited results for quarter and nine months ended 31 Dec 2025. | [Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December, 2025. 31 Jan - Board approved unaudited results for quarter and nine months ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf162130-3236-4b5c-99fe-bd83e3c9424e.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f016abc5-db70-481a-9564-c32203179c43.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3b52609-fbcb-47f3-94b7-8f3097ee1578.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/992bb31d-8c2e-4d5d-af38-2603e333f50e.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d07580aa-6617-4bc8-9acb-a31dda66fc36.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aefe5de5-a105-48b4-a52e-2381f49378ee.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/52dee76d-fe96-4fde-b70d-50de21d40b47.pdf) |
| Apr 2025 | [Concall - Apr 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5e7e7690-378b-43e0-a544-1892f35801ae.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3afda1c-dd02-45b4-9993-6ad5583864da.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed2d9e87-dab6-46ff-b72a-7e861f930d3c.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9c56f1a7-38b2-41ea-8765-4495c3087075.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/73603531201.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/68927531201.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/5312010320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/5312010319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/5312010318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/5312010317.pdf) |
| from bse | [Financial Year 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/531201/5312010316.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:15:39.920Z.